Jeffrey A. Kern

Also affiliated with University of Colorado Denver

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Immune checkpoint inhibitor–related dermatologic adverse events”.

Immune checkpoint inhibitor–related dermatologic adverse events

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.03.132

N/A

0DataRank · unranked

466 citations

Gregory S. Phillips, Dulce M. Barrios, Jennifer Wu, Donald Y.M. Leung, Andrea P. Moy +3 more

Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.024

N/A

0DataRank · unranked

109 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.03.003

N/A

0DataRank · unranked

60 citations

Taras Lyubchenko, Lukas Kraehenbuehl, Mario E. Lacouture, Donald Y.M. Leung, Jeffrey A. Kern +1 more

Immune-related cutaneous adverse events due to checkpoint inhibitors

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.02.009

N/A

0DataRank · unranked

37 citations

Lukas Kraehenbuehl, Kwami F. Ketosugbo, Jeffrey A. Kern, Mario E. Lacouture, Donald Y.M. Leung +1 more

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9092

N/A

0DataRank · unranked

2 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection

Clinical Oncology(2023)10.1016/j.clon.2023.03.015

N/A

0DataRank · unranked

8 citations

Juan P. Wisnivesky, Shannon M. Nugent, Kate Stone, Michael Farris, Jeffrey A. Kern +5 more

Data from Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies

(2023)10.1158/0008-5472.c.6496299

N/A

0DataRank · unranked

0 citations

Titus J. Boggon, Susumu Kobayashi, Cheng Jin, C. Patrick, Afshin Dowlati +4 more

Data from Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies

(2023)10.1158/0008-5472.c.6496299.v1

N/A

0DataRank · unranked

0 citations

Titus J. Boggon, Susumu Kobayashi, Cheng Jin, C. Patrick, Afshin Dowlati +4 more

Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3431

N/A

0DataRank · unranked

32 citations

Elena Goleva, Neil J. Shah, Veronica Rotemberg, Lukas Kraehenbuehl, Kwami F. Ketosugbo +15 more

Phenotype/Immunologic Profiling in ircAEs—Response

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2949

N/A

0DataRank · unranked

0 citations

Mario E. Lacouture, Andrea P. Moy, Jeffrey A. Kern, Donald Y.M. Leung, Elena Goleva

Provider Bias in Decision Making About Treatment of Early-stage Lung Cancer With Stereotactic Body Radiation Therapy or Sub-lobar Resection

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.08.010

N/A

0DataRank · unranked

0 citations

Hamna Zafar, Grace Mhango, Christopher G. Slatore, Raja M. Flores, Scott K. Swanson +4 more